Percentage of bloodstream infection due to methicillin-resistant in Lithuania

Lithuania: Percentage of bloodstream infection due to methicillin-resistant was 9.4% in 2022. ▼ Falling

Latest (2022)
9.4%
Change on year
up 4.9%
World rank
31st
of 44 countries
All-time high
11.6%
in 2016
All-time low
8.4%
in 2018
Years of data
7
2016–2022

Percentage of bloodstream infection due to methicillin-resistant in Lithuania, 2016–2022

02.557.51012.52016201920222016: 11.62017: 8.82018: 8.42019: 9.32020: 9.82021: 92022: 9.4

Source: United Nations Statistics Division, SDG Global Database.

Analysis

Lithuania recorded 9.4% for percentage of bloodstream infection due to methicillin-resistant in 2022.

That represents a change of up 4.9% on the previous year and down 18.8% over ten years.

Lithuania ranks 31st of 44 countries on this measure, in the middle of the range.

Percentage of bloodstream infection due to methicillin-resistant in Lithuania, year by year

Annual values for Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%) in Lithuania, 2016 to 2022.
Year Value Change
2016 11.6%
2017 8.8% -24.1%
2018 8.4% -4.5%
2019 9.3% +10.7%
2020 9.8% +5.4%
2021 9.0% -8.4%
2022 9.4% +4.9%

Averages by decade

DecadeAverage LowestHighest Years
2010s 9.5% 8.4% 11.6% 4
2020s 9.4% 9.0% 9.8% 3

Countries ranked near Lithuania

  1. 28 Tunisia 13.6% compare
  2. 29 France 11.2% compare
  3. 30 Ireland 10.5% compare
  4. 32 United Kingdom of Great Britain and Northern Ireland 8.0% compare
  5. 33 Czechia 7.6% compare
  6. 34 Thailand 7.5% compare

See the full ranking of 61 places →

More development goals data for Lithuania

All data for Lithuania →

Frequently asked questions

What is percentage of bloodstream infection due to methicillin-resistant in Lithuania?
Percentage of bloodstream infection due to methicillin-resistant in Lithuania was 9.4% in 2022, according to United Nations Statistics Division, SDG Global Database.
What is the highest percentage of bloodstream infection due to methicillin-resistant recorded in Lithuania?
The highest recorded value was 11.6% in 2016.
What is the lowest percentage of bloodstream infection due to methicillin-resistant recorded in Lithuania?
The lowest recorded value was 8.4% in 2018.
How does Lithuania rank for percentage of bloodstream infection due to methicillin-resistant?
Lithuania ranks 31st out of 44 countries with data for 2022.
Is percentage of bloodstream infection due to methicillin-resistant rising or falling in Lithuania?
Over the last ten years it is down 18.8%. The long-run trend across the full record is falling.
Where does this Lithuania data come from?
The figures come from United Nations Statistics Division, SDG Global Database, published as part of Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 7 observations, free to reuse under UN SDG Global Database (open, attribution requested).

Share, cite or embed this page

Cite this page

Percentage of bloodstream infection due to methicillin-resistant in Lithuania. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 27 August 2026, from https://development-goals.statizoid.com/stat/percentage-of-bloodstream-infection-due-to-methicillin-resistant-staphylococcus-aureus/lithuania/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/stat/percentage-of-bloodstream-infection-due-to-methicillin-resistant-staphylococcus-aureus/lithuania/">Percentage of bloodstream infection due to methicillin-resistant in Lithuania</a> — Statizoid

About this data

Indicator
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%)
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
61 places, 372 data points, 2016–2022
Last refreshed